Lecap Asset Management Ltd. Invests $729,000 in Teleflex Incorporated (NYSE:TFX)

Lecap Asset Management Ltd. bought a new position in Teleflex Incorporated (NYSE:TFX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,094 shares of the medical technology company’s stock, valued at approximately $729,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its stake in shares of Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock valued at $102,000 after buying an additional 80 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in Teleflex in the 2nd quarter valued at about $918,000. Czech National Bank raised its stake in shares of Teleflex by 6.9% in the third quarter. Czech National Bank now owns 9,598 shares of the medical technology company’s stock worth $2,374,000 after acquiring an additional 623 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Teleflex by 131.1% during the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares in the last quarter. Finally, Mather Group LLC. grew its stake in shares of Teleflex by 180.8% during the third quarter. Mather Group LLC. now owns 292 shares of the medical technology company’s stock valued at $72,000 after purchasing an additional 188 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Mizuho cut their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial cut their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Finally, Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Trading Down 1.4 %

NYSE:TFX opened at $171.13 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $170.30 and a 1-year high of $256.85. The firm has a market capitalization of $7.95 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.72 and a beta of 1.16. The business’s 50-day moving average price is $180.48 and its two-hundred day moving average price is $211.61.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.